SPDR S&P Pharmaceuticals ETF Rating $43.42 +0.17 (+0.39%) (As of 12/20/2024 05:23 PM ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatings SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy 2.69Holdings in XPH have an aggregate rating of Moderate Buy based on 371 analyst ratings issued in the past year covering 45 companies (99.9% of the portfolio).XPH Aggregate Price Target$43.42High Prediction$43.42Average Prediction$43.42Low Prediction$43.42Holdings in XPH have an aggregate price target of $43.42 and a range of $43.42 to $43.42 covering 45 companies (99.9% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy17 Buy rating(s)Moderate Buy20 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 45 XPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.37%CORTCorcept Therapeutics$51.40+0.5%4.9121 of 5 stars3.00$65.25 26.9%5Analyst RevisionHigh Trading Volume4.19%LBPHLongboard Pharmaceuticals$59.98+0.0%0.659 of 5 stars2.44$59.56 -0.7%94.18%BMYBristol-Myers Squibb$57.33+1.8%4.7872 of 5 stars2.25$55.64 -2.9%20High Trading Volume4.01%ITCIIntra-Cellular Therapies$83.45-0.8%4.0477 of 5 stars2.85$97.23 16.5%133.95%JAZZJazz Pharmaceuticals$122.97+0.1%4.8529 of 5 stars2.87$177.00 43.9%15High Trading Volume3.92%VTRSViatris$12.52+3.2%2.056 of 5 stars2.00$13.67 9.2%3News CoverageHigh Trading Volume3.62%AXSMAxsome Therapeutics$90.73+1.1%4.7641 of 5 stars3.00$125.93 38.8%14Positive News3.57%PRGOPerrigo$25.75+0.1%4.9867 of 5 stars2.75$37.00 43.7%4Positive News3.56%CTLTCatalent$63.482.7663 of 5 stars2.00$63.40 -0.1%73.39%EWTXEdgewise Therapeutics$30.78-0.1%2.722 of 5 stars3.00$43.17 40.2%6Analyst ForecastAnalyst Revision3.32%RPRXRoyalty Pharma$24.92+2.6%4.6267 of 5 stars2.83$41.67 67.2%6High Trading Volume3.26%JNJJohnson & Johnson$144.47+0.6%4.8935 of 5 stars2.50$174.73 20.9%14High Trading Volume3.21%ZTSZoetis$164.84+0.8%4.6029 of 5 stars3.09$215.22 30.6%11High Trading Volume3.17%ELANElanco Animal Health$11.63-1.6%3.7742 of 5 stars2.25$16.71 43.7%83.08%PFEPfizer$26.36+2.3%4.9837 of 5 stars2.47$32.14 21.9%17Analyst ForecastOptions VolumeAnalyst RevisionHigh Trading Volume3.07%MRKMerck & Co., Inc.$98.05-1.5%4.9889 of 5 stars2.71$127.13 29.7%21Analyst DowngradeHigh Trading Volume3.03%TARSTarsus Pharmaceuticals$52.91+1.8%0.3236 of 5 stars3.00$54.20 2.4%7Positive News2.99%LLYEli Lilly and Company$767.76+1.3%4.9956 of 5 stars2.81$1,002.22 30.5%21Gap UpHigh Trading Volume2.70%OGNOrganon & Co.$14.58+1.0%4.8019 of 5 stars2.50$21.33 46.3%4High Trading Volume2.54%PBHPrestige Consumer Healthcare$78.72+0.1%3.7982 of 5 stars2.50$85.25 8.3%4Analyst UpgradePositive NewsHigh Trading Volume2.52%ARVNArvinas$18.48+3.6%2.0251 of 5 stars2.93$63.50 243.6%15High Trading Volume2.18%SUPNSupernus Pharmaceuticals$35.43-1.0%2.5059 of 5 stars2.50$36.00 1.6%2High Trading Volume2.01%AMPHAmphastar Pharmaceuticals$39.14-0.6%4.8626 of 5 stars2.50$60.33 54.1%4High Trading Volume1.99%PCRXPacira BioSciences$18.98-3.0%3.7422 of 5 stars2.20$23.50 23.8%10Gap DownHigh Trading Volume1.93%LGNDLigand Pharmaceuticals$114.64+0.6%4.983 of 5 stars3.00$147.00 28.2%6Analyst RevisionHigh Trading Volume1.55%COLLCollegium Pharmaceutical$29.70-2.4%3.8414 of 5 stars2.60$42.60 43.4%5News CoveragePositive NewsHigh Trading Volume1.54%ANIPANI Pharmaceuticals$53.35-1.7%4.836 of 5 stars3.00$77.71 45.7%8Insider TradeHigh Trading Volume1.43%OCULOcular Therapeutix$8.50+0.6%3.6452 of 5 stars2.86$16.71 96.6%7Positive News1.30%HRMYHarmony Biosciences$34.28+1.2%4.7827 of 5 stars2.60$49.80 45.3%10Analyst ForecastAnalyst RevisionHigh Trading Volume1.24%AMRXAmneal Pharmaceuticals$7.78+0.4%2.8823 of 5 stars2.80$10.00 28.5%5Analyst DowngradeNews Coverage1.20%MNMDMind Medicine (MindMed)$7.16+2.1%2.947 of 5 stars3.25$26.75 273.6%12Analyst ForecastNews Coverage1.17%WVEWave Life Sciences$13.51+2.4%4.8765 of 5 stars3.00$22.22 64.5%9High Trading Volume1.17%HROWHarrow$34.22-0.6%2.3891 of 5 stars3.00$63.00 84.1%3Positive News1.03%LQDALiquidia$11.10+4.8%3.4225 of 5 stars3.11$25.38 128.6%9Analyst ForecastNews CoveragePositive NewsHigh Trading Volume0.99%INVAInnoviva$17.84-0.5%1.9799 of 5 stars3.001High Trading Volume0.91%PLRXPliant Therapeutics$13.21-0.7%3.3626 of 5 stars3.13$40.50 206.6%8High Trading Volume0.91%FULCFulcrum Therapeutics$4.35+7.9%1.7135 of 5 stars2.20$9.33 114.6%10High Trading Volume0.82%EYPTEyePoint Pharmaceuticals$7.10-0.3%1.9425 of 5 stars3.00$25.71 262.2%9News CoverageGap DownHigh Trading Volume0.68%NMRANeumora Therapeutics$10.85+3.3%2.4671 of 5 stars2.83$23.40 115.7%6Analyst RevisionGap DownHigh Trading Volume0.63%ELVNEnliven Therapeutics$22.47-1.7%2.7848 of 5 stars3.20$38.25 70.2%50.61%NUVBNuvation Bio$2.68-0.4%2.3903 of 5 stars3.00$6.60 146.3%5News CoverageHigh Trading Volume0.57%EOLSEvolus$10.89+0.2%3.8237 of 5 stars3.00$23.00 111.2%40.48%PHATPhathom Pharmaceuticals$7.45-4.7%2.9962 of 5 stars2.75$23.00 208.7%4High Trading Volume0.48%XERSXeris Biopharma$3.49+2.3%3.6033 of 5 stars2.67$4.87 39.4%3News CoveragePositive News0.38%SAVACassava Sciences$2.35+2.6%4.4003 of 5 stars2.50$111.50 4,644.7%2News CoverageGap Down This page (NYSEARCA:XPH) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
